BioEnvelop Technologies Corporation — Investor Relations & Filings
Filings indexed
18
across all filing types
Latest filing
2006-05-31
Regulatory Filings
Country
CA
Canada
Listing
TSXV
BIE
BioEnvelop Technologies Corporation specialized in the research, development, and manufacturing of innovative bio-based materials, primarily focusing on advanced oral delivery systems. The company's core offering was a rapidly dissolving edible film strip technology utilized by the nutraceutical and pharmaceutical sectors. This platform enabled the production of thin-film formats for nutritional supplements and supergeneric drugs, providing a unique, efficient delivery mechanism. The company entered into exclusive manufacturing agreements with contract manufacturers and pharmaceutical firms to leverage this technology. BioEnvelop's assets and intellectual property were acquired by specialty pharmaceutical firm Paladin Labs Inc. in 2007.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material change report - English.PDF | 2006-05-31 | English | |
| Material change report - English.PDF | 2006-03-09 | English | |
| Material change report - English.PDF | 2005-07-08 | English | |
| Material change report - English.PDF | 2005-05-18 | English | |
| Material change report - English.PDF | 2004-12-09 | English | |
| Material change report - English.pdf | 2003-12-23 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2006
2 filings
| |||||
| 47638991 | Material change report - English.PDF | 2006-05-31 | English | ||
| 47638995 | Material change report - English.PDF | 2006-03-09 | English | ||
|
2005
2 filings
| |||||
| 47638999 | Material change report - English.PDF | 2005-07-08 | English | ||
| 47639067 | Material change report - English.PDF | 2005-05-18 | English | ||
|
2004
1 filing
| |||||
| 47639071 | Material change report - English.PDF | 2004-12-09 | English | ||
|
2003
1 filing
| |||||
| 47639075 | Material change report - English.pdf | 2003-12-23 | English | ||
|
2002
5 filings
| |||||
| 47639084 | Material change report - English.pdf | 2002-12-10 | English | ||
| 47639088 | Material change report - English.pdf | 2002-08-01 | English | ||
| 47639091 | Other.pdf | 2002-01-03 | English | ||
| 47639096 | Other.pdf | 2002-01-03 | English | ||
| 47639100 | Other.pdf | 2002-01-03 | English | ||
|
2001
4 filings
| |||||
| 47639104 | Other.pdf | 2001-08-15 | English | ||
| 47639131 | Decision Document (Final).pdf | 2001-08-01 | English | ||
| 47639259 | Consent letter of underwriters' legal counsel.pdf | 2001-07-31 | English | ||
| 47639268 | Other.pdf | 2001-07-31 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
cbdMD, Inc.
Producer and distributor of health and wellness CBD product…
|
YCBD | US | Manufacturing |
|
CCSB
Specialized manufacturer of APIs for oncology, antifungal, …
|
1762 | TW | Manufacturing |
|
CDT Equity Inc.
A clinical-stage biopharmaceutical firm advancing assets fo…
|
CDT | US | Manufacturing |
|
Ceapro Inc.
Develops and commercializes natural active ingredients deri…
|
CZO | CA | Manufacturing |
|
CELADON PHARMACEUTICALS PLC
Researches, cultivates, and manufactures cannabinoid-based …
|
CEL | GB | Manufacturing |
|
Celemics, Inc.
Develops NGS target enrichment solutions for research and c…
|
331920 | KR | Manufacturing |
|
Cellbion Co., Ltd
Develops radiopharmaceuticals and radioligand therapies for…
|
308430 | KR | Manufacturing |
|
CELL BIOTECH CO ., LTD
Develops and manufactures probiotic solutions using patente…
|
049960 | KR | Manufacturing |
|
Celldex Therapeutics, Inc.
Develops antibody-based immunotherapies for severe inflamma…
|
CLDX | US | Manufacturing |
|
Cellectar Biosciences, Inc.
Clinical-stage biopharma developing targeted cancer treatme…
|
CLRB | US | Manufacturing |
BioEnvelop Technologies Corporation via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/44781/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=44781 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=44781 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=44781 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 44781}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioEnvelop Technologies Corporation (id: 44781)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.